|Daily Range||$21.12 - $21.83|
|52-Week Range||$18.28 - $28.48|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||205,255|
|Current FY EPS||$0.66|
Emergent BioSolutions (EBS) Description
Emergent BioSolutions makes the only FDA-approved anthrax vaccine. Website: http://www.emergentbiosolutions.com/
Gilead Sciences is widely known for its HIV drug portfolio and for its high-profile hep-C drug sofosbuvir. But it also has a potential winner with idelalisib, a blood cancer drug with a promising future.